Acute angiotensin receptor blockade and mnemonic discrimination in healthy participants.
Prasad D. et al, (2025), J Affect Disord, 375, 293 - 296
Social stress induces autoimmune responses against the brain
Shimo Y. et al, (2023), Proceedings of the National Academy of Sciences, 120
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey Study.
Lindner JR. et al, (2023), JMIR Med Educ, 9
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
Anand A. et al, (2023), N Engl J Med, 388, 2315 - 2325
Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility
Russo S. et al, (2023)
A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adults.
Costi S. et al, (2023), Neurobiol Stress, 22
Exaggerated amygdala response to threat and association with immune hyperactivity in depression
Boukezzi S. et al, (2022), Brain, Behavior, and Immunity, 104, 205 - 212
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants
Costi S. et al, (2022), CNS Drugs, 36, 207 - 216
Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression
Cathomas F. et al, (2022), Translational Psychiatry, 12
Treatment-resistant depression: Therapeutic options when first-line treatments fail
Wigg C. and Costi S., (2022), BJPsych Advances, 28, 4 - 8
Ketamine as a prophylactic resilience-enhancing agent.
Evers AG. et al, (2022), Front Psychiatry, 13
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence
Norbury A. et al, (2021), Neuropsychopharmacology, 46, 2266 - 2277
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
Costi S. et al, (2021), Translational Psychiatry, 11
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Costi S. et al, (2021), American Journal of Psychiatry, 178, 437 - 446
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Feder A. et al, (2021), American Journal of Psychiatry, 178, 193 - 202
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
Tan A. et al, (2020), Molecular Psychiatry, 25, 1323 - 1333
Ketamine normalizes subgenual cingulate cortex hyper-activity in depression
Morris LS. et al, (2020), Neuropsychopharmacology, 45, 975 - 981
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial
Costi S. et al, (2019), Neuropsychopharmacology, 44, 1812 - 1819